Original Contributions |
From the Divisions of Cardiovascular Diseases (S.T.) and of Endocrinology and Metabolism (A.P.-T., S.A., F.S., C.L., P.D.R.), Department of Medicine, University of California at San Diego, La Jolla, Calif.
Correspondence to Peter D. Reaven, MD, Department of Medicine, 0682, UCSD School of Medicine, 9500 Gilman Dr, La Jolla, CA 92093-0682. E-mail preaven{at}ucsd.edu
| Abstract |
|---|
|
|
|---|
Key Words: diet lipoproteins arteriosclerosis lipids LDL oxidation
| Introduction |
|---|
|
|
|---|
However, with a greater understanding of the mechanisms contributing to the development of atherosclerosis, it has become clear that dietary fat composition may also influence the development of atherosclerosis by mechanisms other than lowering plasma cholesterol levels.13 Several lines of evidence suggest that the oxidation of lipoproteins plays an important role in the early events leading to atherosclerotic lesion formation. When LDL becomes oxidized it takes on a variety of atherogenic properties.13 14 15 For example, when LDL is minimally oxidized (mm-LDL), it is capable of stimulating cell expression of a variety of cytokines and adhesion molecules that may enhance monocyte chemotaxis, transmigration, and adhesion, as well as stimulating monocyte differentiation into macrophages.15 16 17 18 More extensively oxidized LDL, in addition to stimulating monocyte chemotaxis, is also toxic to endothelial cells, decreases endothelium-derived relaxing factormediated vasodilation, and is taken up in an unregulated fashion by macrophages, thereby generating foam cells.13 14 15 18 The susceptibility of LDL to oxidation is influenced by a variety of factors, including its antioxidant and fatty acid content. Polyunsaturated fatty acids (PUFAs) in LDL are readily oxidized, and their replacement by MUFAs appears to reduce LDL oxidation.13 19
Previous studies assessing dietary fat composition and LDL oxidation have been carried out in artificial settings, such as metabolic wards or communal living conditions, and have instituted highly restrictive dietary guidelines. In general, these studies have utilized carefully prepared, liquid-formula or solid diets highly enriched in MUFAs, have usually provided the subjects with all the required foods, and have closely monitored subjects to ensure compliance. These investigations have demonstrated that in comparison with PUFA-enriched diets, feeding MUFA-enriched diets to both normocholesterolemic and hypercholesterolemic subjects reduces LDL susceptibility to oxidation.20 21 22 Similar results were found when MUFA diets were compared with carbohydrate-enriched diets.12 23 It is unknown whether a more realistic level of MUFA enrichment will lead to similar results. In this study, we evaluated whether LDL isolated from Greek subjects who were consuming a "typical" unsupplemented Mediterranean-style diet rich in olive oil was more resistant to oxidation and less readily converted to a bioactive mm-LDL.
| Methods |
|---|
|
|
|---|
The second study included 13 subjects from the United States who had participated in a previous trial testing the effects of dietary modifications on the susceptibility of LDL to oxidation.21 These healthy, mildly hypercholesterolemic subjects consumed a liquid diet enriched in either oleate (n=6) or linoleate (n=7) as their main source of nutrition for 8 weeks. The liquid diets were prepared according to the method of Mattson and Grundy24 by using oleate-enriched sunflower oil (Trisun 80) and conventional sunflower oil. The details of this study protocol have been described previously.21 Plasma samples prepared from these subjects at the end of the 8-week study had been frozen at -70°C for 5 years before being thawed and used in the current study. LDL was isolated from these samples, fatty acid contents of LDL and LDL vitamin E levels were measured, and the LDL was subsequently used in the monocyte chemotaxis and adhesion assays as described below. None of the data presented in this article have been published previously.
Subjects from both studies were without acute or chronic medical conditions, and none were taking lipid-lowering medications or antioxidant supplements. These studies were approved by the Human Studies Committee of the University of California, San Diego, and were conducted in part at the outpatient facilities of the University of California, San Diego, General Clinical Research Center.
Preparation of LDL
Fasting blood samples were obtained from each subject into tubes
containing EDTA (4.0 mmol/L) and placed immediately on ice, and
the plasma was then separated. A final concentration of 0.22
mmol/L gentamicin, 0.15 mmol/L chloramphenicol, and 1
µmol/L
D-phenylalanyl-L-propyl-L-arginine
chloromethyl ketone was added to all plasma samples and all solutions
used subsequently during LDL isolation. The Greek plasma samples were
sealed in an airtight container and shipped on ice to the United States
within 24 hours. All plasma samples were frozen at -70°C in sucrose
(17.5 µmol/L final concentration) to cryopreserve the LDL as
described previously.25 26 Plasma samples from
each group were then thawed simultaneously, and LDL was
isolated by sequential ultracentrifugation as
previously described20 and dialyzed extensively
against PBS containing 0.27 mmol/L EDTA (PBS-EDTA). Plasma total
cholesterol, LDL cholesterol,
triglycerides, and HDL were measured by enzymatic assays on
an automated Abbott VP Super System bichromatic
analyzer.21
Measurement of LDL conjugated-diene formation during copper-mediated oxidation was carried out immediately after isolation, as described below. LDL samples were subsequently stored at 4°C in the dark, and all other studies were completed within 1 week of isolation. For all oxidation assays, LDL samples were dialyzed against several changes of PBS over 20 hours to remove all EDTA before use in experiments.
Fatty Acid Composition
Lipids from LDL were extracted by a modification of the method
of Folch et al.27 The fatty acids were
trans-methylated and analyzed in a Varian gas
chromatograph model 3700 equipped with a column of 10% Silar
5CP on a Gas Chrom QII, 100/120 mesh. A 15:0 internal standard
(pentadecanoic acid) was added to each sample before extraction, and
calculations of fatty acid amounts were determined from peak area
ratios of sample to internal standard.
Vitamin E Content
-Tocopherol was measured by
high-performance liquid chromatography as
described previously.22
-Tocopherol acetate was prepared in 100% ethanol and
used as an extraction internal standard and for standard-curve
preparation. Actual concentrations of
-tocopherol were
determined by measuring the absorbance of prepared solutions and
calculating the concentrations based on known spectral data.
Calculations were determined from a standard curve of peak area ratios
of sample to internal standard.
Oxidation of LDL
LDL oxidation was assessed as both the lag time before
initiation of rapid oxidation of LDL particles and as the extent of
conjugated-diene formation. Seventy-five micrograms of LDL protein was
incubated with 2.5 µmol/L CuSO4 in 1 mL of
PBS at 30°C, and the absorbance at 234 nm was measured continuously
in a Uvikon 810 spectrophotometer as described.28
For data presentation, the first derivative of the rapid
phase of oxidation was calculated (slope), and its intercept with the
x axis (lag time) determined; OD at 234 nm was then
determined for assessment of maximal conjugated-diene formation. In
some experiments, lipid peroxidation was also assessed by determining
the formation of thiobarbituric acidreactive substances (TBARS) in
the samples, as described by Yagi.29
Cell Culture Procedures
Murine fibroblasts expressing high levels of intracellular
15-lipoxygenase (15-LO) were established by infection
with a retroviral vector as previously
described.30 Cells were grown in Dulbecco's
modified essential medium with high glucose, containing 10% FCS and
G418 sulfate (50 µg/mL), at 37°C and under 5%
CO2. Fibroblasts were plated on 96-well plates at
35 000 cells per well and grown for 2 days until nearly confluent. The
cells were then washed free of serum, and LDL (250 µg/mL) was then
incubated with the fibroblasts at 37°C for 20 hours in Hams F-10
medium to induce mild oxidation and generate
mm-LDL,31 which was subsequently used in the
monocyte chemotaxis and adhesion assays described below.
Monocyte Chemotaxis Assay
Human monocytes were isolated by a modification of the method of
Boyum.32 In brief, mononuclear cells were
recovered from the interface formed during
ultracentrifugation of the white blood cell pellet on a
Histopaque gradient. Cells were then washed in PBS containing 0.02%
EDTA-PBS, resuspended in autologous serum (10%) and RPMI-1640 medium,
and plated. After a 2-hour incubation at 37°C, nonadherent cells were
washed off, leaving a highly enriched monocyte preparation. The
remaining adherent cells were then gently released by using 0.2%
EDTA-PBS in 10% dimethyl sulfoxide, 30% serum, and 60% RPMI-1640
medium. The monocytes were then frozen at -70°C and stored in
LN2 until use for subsequent monocyte chemotaxis
assays. Chemotaxis assays were performed in Neuroprobe chambers with a
polycarbonate filter (Poretics) of 5-µm-pore size separating the
upper and lower chambers. Approximately 100 000 monocytes were added
to each upper well, the lower wells were filled with 28 µL of
supernatant (1:20, in 0.1% BSATyrode's salt solution) from the
fibroblast incubation experiments, and the chambers were treated as
previously described by Berliner et al.33 The
number of monocytes per high-power field that had migrated to the lower
surface of the filter was then counted by using a light microscope.
Monocyte Adhesion Assay
The assay used was a modification of the method of Navab et
al.34 Native LDL or LDL conditioned by incubation
with fibroblasts in F-10 medium for 20 hours was transferred to
confluent, porcine aortic endothelial monolayers in
96-well tissue culture plates. After a 4-hour incubation at 37°C, the
supernatant was removed and the endothelial monolayers
washed twice with RPMI 1640. THP-1 cells (a monocyte-like cell line)
were placed on the endothelial cells at 40 000 cells
per well, and the plates were incubated for 20 minutes at 37°C. The
suspension was removed, and the cells were vigorously washed 3 times to
remove all but the firmly adherent THP-1 cells. The number of adherent
THP-1 cells was determined in 4 high-power fields per well, and the
results of 6 to 8 separate wells were averaged for each experiment.
To determine whether LDL isolated from frozen plasma yielded results similar to those of LDL isolated from fresh plasma in our monocyte chemotaxis and THP-1 cell adhesion assays, we performed the following experiments. Plasma aliquots from 2 individuals were either kept in the dark at 4°C or frozen at -70°C for 3 days. LDL was then isolated from each sample and conditioned on the 15-LO fibroblasts as described above. The level of chemotactic activity and THP-1 cell adhesion stimulated by the cell-conditioned LDL was nearly identical to that for LDL prepared from fresh or thawed plasma.
Statistical Analysis
Initial analyses confirmed that the data were normally
distributed. One-way ANOVA was used to compare values between multiple
groups, and post hoc comparisons between specific groups were performed
by Student's unpaired t test. Data are presented as
mean±SE.
| Results |
|---|
|
|
|---|
|
Fatty Acid Composition of Olive Oil
Greek olive oil that is typical of that produced along the
northwestern Ionian coast region was tested for its fatty acid content.
It contained 73% MUFAs, essentially all in the form of oleic acid,
13% PUFAs, and 14% saturated fatty acids. The fatty acid composition
is comparable to other commercially available olive
oils.35
Fatty Acid Content of LDL
The fatty acid composition of LDL was determined for all patients
and is shown in Table 2
. The mean oleic
acid content in LDL was 20% higher in the Greek subjects than in the
Americans or Greek-Americans. (Oleic acid content
represented 24.2% of the total fatty acid content of LDL
in the Greek subjects compared with 19.6% in the Americans and 19.5%
in the Greek-Americans, P<0.001.) Correspondingly, total
measured PUFAs in LDL were lower in the Greek subjects. There was also
a small but significant increase in palmitic acid content in the Greek
subjects compared with that in the Greek-Americans only, but there was
no significant difference in palmitoleate or stearic acid content.
These differences in the LDL fatty acid content reflected the higher
content of oleic acid and the lower content of PUFAs in Greek olive
oil. The ratio of 18:1 to 18:2 in LDL was higher in the Greek subjects,
at 0.71, versus 0.52 in the Americans and 0.51 in the Greek-Americans
(P<0.001 by ANOVA), confirming an overall proportional rise
in MUFA content. When linoleic and arachidonic acid
contents in LDL were combined as a measure of the total PUFA content,
there was still a higher ratio of MUFAs to PUFAs in the Greek subjects
(MUFA-PUFA ratio. 0.58 in the Greeks) versus 0.41 in the Americans and
0.40 in the Greek-Americans (P<0.001 by ANOVA).
|
LDL Vitamin E Levels
There was no significant difference in the LDL vitamin E levels
among the Greek, American, and Greek-American subjects (Greeks,
5.6±0.3 µg/mg LDL protein versus American, 5.2±0.2 µg/mg LDL
protein, versus Greek-Americans, 5.9±0.4 µg/mg LDL protein).
LDL Oxidation
There were no significant differences in lag times between the 3
groups (102±20 minutes for the Greeks, 106±22 for the Americans, and
105±22 for the Greek-Americans, P=0.6). The extent of LDL
oxidation was measured by the peak OD at 234 nm of generated conjugated
dienes (which primarily reflect the total substrate available for
oxidation) during oxidation of LDL. There was a significant difference
among the groups as measured by ANOVA (P<0.02). There was a
significantly lower amount of conjugated dienes generated in LDL from
Greek subjects compared with LDL from the Greek-Americans (peak OD of
1.29±0.03 versus 1.46±0.05, P<0.008), but no significant
difference was present between the Greek and American subjects
(peak OD of 1.29±0.03 versus 1.34±0.05, P=0.20). Because
there were no significant differences in fatty acid composition,
vitamin E levels, or susceptibility to oxidation between LDL samples
from the Americans and Greek-Americans, these 2 American groups were
combined for further analysis of copper-mediated LDL oxidation.
The combined American and Greek-American group had a significantly
higher peak OD value, consistent with a greater extent of
oxidation, than did the Greek subjects (peak OD of 1.29±0.03 versus
1.39±0.05, P=0.017).
Figure 1A
shows that there was a
moderately strong correlation between the 18:2 content and the peak OD
(r=0.63, P=0.005) and a trend toward a negative
correlation between 18:1 and peak OD (r=-0.32,
P=0.11) in the Greek subjects. Similar results were noted in
the combined American and Greek-American group in Figure 1B
(18:2 and
peak OD, r=0.53, P=0.003; and 18:1 and peak OD
r=-0.35, P=0.07). When all subjects were
combined there was a strong, positive correlation between the 18:2
content and the peak OD (r=0.60, P<0.001) and a
strong, negative correlation between 18:1 content and peak OD
(r=-0.44, P=0.002).
|
Monocyte Chemotaxis and Adhesion Assays
Monocyte chemotactic activity induced by mild oxidation of LDL by
fibroblasts overexpressing 15-LO was assessed in LDL from 10 Greek
subjects and 10 age- and sex-matched American LDL samples.
(Greek-American LDL samples were not studied.) We have previously shown
that incubation of LDL with fibroblasts overexpressing 15-LO, but not
with control cells, leads to the generation of mm-LDL that
stimulates monocyte chemotactic activity and monocyte adhesion to
endothelial cells.31 This process
has been shown to be dependent on lipoprotein oxidation, because the
presence of antioxidants, such as vitamin E and probucol, or
transition-metal chelators inhibit the generation of
bioactivity.31 Although many lines of evidence
suggest that 15-LO may be an important contributor to oxidation of
lipoproteins in vivo,30 31 there is still
controversy regarding this issue. In this study, the 15-LO fibroblasts
were being used primarily as a reliable system for generating a mildly
oxidized and bioactive lipoprotein.31
After modification by 15-LO cells, LDL from Greek subjects induced 42%
less monocyte chemotactic activity compared with LDL from American
subjects (P<0.001, Figure 2
).
Consistent with previously published studies, development of
chemotactic activity required conditioning on 15-LO cells, because
neither LDL conditioned in medium alone nor "native" LDL samples
(tested in a subset of 5 subjects per group) demonstrated significant
chemotactic activity (data not shown). When values from all 20 subjects
were combined, there was a strong, negative correlation between 18:1
levels and monocyte chemotactic activity (r=-0.64,
P<0.001, Figure 3
). There was
also a positive correlation between the content of 20:4
(r=0.62, P=0.003) and 18:2 (r=0.36,
P=0.11) and monocyte chemotactic activity, as well as
between total PUFAs (18:2 and 20:4) in LDL and the increase in monocyte
chemotactic activity (r=0.51, P<0.01, Figure 3
).
Lipid peroxidation as measured by the TBARS assay on 15-LOconditioned
LDL samples was lower in the Greek group, but this difference was not
statistically significant (10.8±0.4 nmol/mg LDL protein in the Greeks
versus 12.0±0.8 nmol/mg LDL protein in the Americans,
P=0.25). In a subset of subjects (5 subjects per group), we
also tested the ability of modified LDL to stimulate THP-1 cell
adhesion to endothelial cells. LDL isolated from Greek
subjects and incubated on 15-LO cells stimulated significantly less
THP-1 cell adhesion to endothelial cells than did
conditioned LDL from American subjects (21.7±12.2 versus 45.0±7.3
THP-1 cells per field, P=0.01). LDL samples from both diet
groups that were conditioned in medium alone induced only low levels of
THP-1 cell adhesion that were not significantly different between
groups.
|
|
To confirm that the high content of dietary oleic acid and lower
content of PUFAs but not other components in the Mediterranean diet may
be directly responsible for the decreased bioactivity of LDL, we
studied LDL samples from 13 subjects fed oleic or linoleic
acidenriched diets that were prepared by the Clinical Research
Nutrition Unit at the University of California, San Diego. The
composition of these diets has been described
previously.20 22 The oleic acid content of LDL
from oleate-supplemented subjects was 113% higher than in LDL from the
linoleate-supplemented subjects (25.6% of the total fatty acid content
in LDL versus 12.0%, respectively, P<0.001). In contrast,
the linoleate content in LDL from the linoleate-supplemented subjects
was 46% higher than that in LDL from the oleate-supplemented subjects
(52.1% versus 35.6%, P<0.001, Table 2
). Of note, the
fatty acid composition of these LDL samples was quite similar to that
originally measured on LDL isolated from these same plasma samples 5
years previously.21 In addition, the fatty acid
composition of LDL from subjects fed liquid-formula diets enriched in
oleic acid was very similar to that of LDL from Greek subjects eating a
diet naturally enriched in olive oil (Table 2
). The vitamin E content
in LDL was not significantly different between the oleate- and
linoleate-supplemented groups.
After incubation on 15-LO cells, the conditioned LDL samples were
tested for their ability to induce monocyte chemotaxis and THP-1 cell
binding to endothelial cells. The monocyte chemotactic
activity of oleate-enriched LDL was 52% lower (P<0.001)
than that of linoleate-enriched LDL (Figure 4A
). Similarly, after conditioning on
15-LO cells, oleate-enriched LDL reduced THP-1 cell adhesion to
endothelial cells by 77% (P<0.001)
compared with linoleate LDL (Figure 4B
). There was a strong, positive
correlation between the content of PUFAs (18:2 and 20:4) in LDL and the
increase in monocyte chemotaxis (r=0.56,
P<0.001) as well as a negative correlation between 18:1
levels and monocyte chemotaxis (r=-0.45,
P<0.001). A strong, negative correlation was also noted
between 18:1 levels in LDL and THP-1 cell adhesion
(r=-0.73, P<0.001), and a positive correlation
was present between PUFAs (18:2 and 20:4) and THP-1 cell adhesion
(r=0.87, P<0.001, Figure 5A
and 5B
, respectively). Measures of
lipid peroxidation (TBARS) on 15-LOconditioned LDL samples were not
significantly different between groups (12.6±0.9 nmol/mg LDL protein
in the oleate-supplemented subjects versus 14.2±0.8 in the
linoleate-supplemented subjects, P=NS).
|
|
| Discussion |
|---|
|
|
|---|
Although it is conceivable that there may be other differences aside from the diets, including genetic or other cultural factors, between Greeks and Americans that might explain differences in lipoprotein oxidation, we could find no evidence for this possibility. Greek-Americans living in the United States had values of LDL oxidation similar to those of Americans, and cigarette and medication usage was minimal in all groups.
It has been demonstrated that mm-LDL is quite bioactive and in vitro is capable of stimulating gene expression and synthesis of a variety of proinflammatory proteins in several cell types present in the artery wall.15 17 18 Injection of mm-LDL in animal models indicates that these bioactive effects appear to be maintained in vivo.18 42 Therefore, it has been suggested that the generation of mm-LDL may be a very important early step in atherogenesis. Recent studies by several investigators have implicated oxidative decomposition products of lipoprotein phospholipids as possible proinflammatory agents responsible for some of the bioactivity of mm-LDL. In particular, several oxidation products of 1-palmitoyl-2-arachidonoyl-sn-glyero-3-phosphocholine appear capable of stimulating monocyte chemotaxis and transmigration, as well as stimulation of monocyte adhesion to endothelial cells.43 We have recently shown that oxidation products of other PUFAs such as 18:2, when incorporated into phospholipids in liposomes, may also be proinflammatory.44 This observation may explain the strong correlation found in the current study between total LDL PUFA content and induction of monocyte chemotaxis by LDL conditioned on 15-LO cells. In this light it is not surprising that 18:1-enriched and 18:2- and 20:4-depleted LDL from Greek subjects was not only less extensively oxidized by exposure to copper but was also significantly less able to stimulate monocyte chemotaxis and adhesion compared with LDL from Americans. This latter effect appeared to be related to the LDL fatty acid composition, as further studies on samples from individuals fed specially prepared diets enriched in 18:1 and depleted of 18:2 revealed strikingly similar results; ie, both monocyte chemotaxis and stimulation of monocyte adhesion to endothelial cells were dramatically reduced. An important difference in these latter studies is that the diets differed only in the quantity of 18:1 or 18:2 in their diets. In addition, as in the first set of studies, bioactivity measurements of monocyte chemotaxis and adhesion were correlated positively with content of 18:2 and 20:4 in LDL and inversely with 18:1. The mechanism by which oleic acidenriched diets decrease lipoprotein susceptibility to oxidation is presumably related to the resulting decrease in linoleic acid content within lipoproteins. However, recent work from our laboratory demonstrates that liposomes derived from synthetic phospholipids that are progressively enriched in oleic acid while keeping linoleic acid content steady induce less monocyte chemotaxis and adhesion when exposed to mild oxidative stress, suggesting that oleic acid may have an additional independent mechanism of action.44
Interestingly, despite having significantly reduced measures of bioactivity, oleic acidenriched samples had only modestly lower levels of TBARS than did 18:2-enriched LDL. This apparent disassociation between the extent of lipid peroxidation and bioactivity that occurs with mild cell-mediated oxidative stress has been noted previously.31 45 However, generation of bioactive LDL is dependent on LDL oxidation, as we have previously demonstrated that lipid oxidation and loss of PUFAs occur and that the addition of antioxidants or transition metal chelators inhibits generation of bioactivity.31 15-LO cells may be inducing generation of unique (or greater levels of) bioactive compounds in oxidation-susceptible 18:2-enriched LDLs that are not detected by TBARS measurements. Alternatively, the TBARS assay may be insufficiently sensitive or specific to detect modest but important differences in lipid oxidation products between LDL samples.31 46
Although it has been well demonstrated that replacement of dietary saturated fat with monounsaturated fat has beneficial effects on plasma cholesterol levels, these current studies point out several potential advantages of diets enriched in 18:1 and depleted in 18:2 on lipoprotein oxidation and its biological consequences. These findings may offer additional insight into understanding possible mechanisms underlying the reduced cardiovascular risk in Mediterranean countries. The Seven Countries and the Framingham Heart Studies1 2 4 were crucial in defining the epidemiological association between dietary fat intake, hypercholesterolemia, and atherosclerosis. However, there have been few controlled studies assessing the effect of consuming a Mediterranean-style diet on cardiovascular outcomes.47 48 49 50 As a whole, these studies have suggested that patients who adhere to a Mediterranean-style diet composed of a higher proportion of legumes, fruits, vegetables, and grains; less red meat; more fish; and a significant reduction in saturated fats replaced by monounsaturated or polyunsaturated fats have a reduced incidence of coronary heart events. In particular, a recent clinical trial of the Mediterranean diet conducted in patients with a previous myocardial infarction provides evidence of the ability of these diets to reduce subsequent cardiovascular events.48 49 51 Importantly, this reduction in cardiovascular events was independent of changes in plasma cholesterol levels.49
Previous dietary studies have shown that in comparison with PUFA-enriched diets, MUFA-enriched diets result in enrichment of LDL with MUFAs that reduce LDL susceptibility to oxidation.20 21 22 41 The current study of "natural" diets clearly demonstrates that the level of dietary enrichment with oleic acid necessary to obtain these benefits is realistic and readily achieved with diets currently in use in Mediterranean countries. In addition, this study suggests that LDL enriched with 18:1 and depleted in 18:2 and 20:4 may be less readily converted to proinflammatory mm-LDL, which has the ability to enhance early events in atherosclerosis such as monocyte chemotaxis and adhesion.
| Acknowledgments |
|---|
| Footnotes |
|---|
Received January 6, 1998; accepted June 15, 1998.
| References |
|---|
|
|
|---|
2.
Castelli WP, Garrison RJ, Wilson PW, Abbott RD,
Kalousdian S, Kannel WB. Incidence of coronary heart disease
and lipoprotein cholesterol levels: the Framingham Study.
JAMA. 1986;256:28352838.
3.
Steinberg D. The cholesterol controversy
is over: why did it take so long? Circulation. 1989;80:10701078.
4.
Keys A, Menotti A, Karvonen MJ, Aravanis C, Blackburn
H, Buzina R, Djordjevic BS, Dontas AS, Fidanza F, Keys MH, Kromhout D,
Nedeljkovic S, Punsar S, Seccareccia F, Toshima H. The diet and 15-year
death rate in the Seven Countries Study. Am J
Epidemiol. 1986;124:903915.
5. Hegsted DM, McGandy RB, Myers ML, Stare FJ. Quantitative effects of dietary fat on serum cholesterol in man. Am J Clin Nutr. 1965;7:281295.
6. Ahrens EH, Insull W, Blomstrand R, Hirsch J, Tsaltas TT, Peterson ML. The influence of dietary fats on serum-lipid levels in man. Lancet. 1957;2:943953.
7. Trichopoulou A, Kouris-Blazos A, Vassilakou T, Gnardellis C, Polychronopoulous E, Venizelos M, Lagiou P, Wahlqvist ML, Trichopoulos D. Diet and survival of elderly Greeks: a link to the past. Am J Clin Nutr. 1995;61:1346S1350S.[Abstract]
8.
Mensink RP, Katan MB. Effect of dietary fatty acids on
serum lipids and lipoproteins. Arterioscler Thromb. 1992;12:911919.
9.
Grundy SM, Florentin L, Nix D, Whelan MF. Comparison
of monounsaturated fatty acids and carbohydrates
for reducing raised levels of plasma cholesterol in man.
Am J Clin Nutr. 1988;47:965969.
10.
Grundy SM, Nix D, Whelan MF, Franklin L. Comparison of
three cholesterol-lowering diets in normolipidemic men.
JAMA. 1986;256:23512355.
11. Mensink RP, Katan MB. Effect of a diet enriched with monounsaturated or polyunsaturated fatty acids on levels of low-density and high-density lipoprotein cholesterol in healthy women and men. N Engl J Med. 1989;321:436441.[Abstract]
12.
Berry EM, Eisenberg S, Friedlander Y, Harats D,
Kaufmann NA, Norman Y, Stein Y. Effects of diets rich in
monounsaturated fatty acids on plasma lipoproteins:
the Jerusalem Nutrition Study, II: monounsaturated
fatty acids vs. carbohydrates. Am J Clin Nutr. 1992;56:394403.
13. Reaven PD, Witztum JL. Oxidized low density lipoproteins in atherogenesis: role of dietary modification. Annu Rev Nutr. 1996;16:5171.[Medline] [Order article via Infotrieve]
14. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med. 1989;320:915924.[Medline] [Order article via Infotrieve]
15.
Berliner JA, Navab M, Fogelman AM, Frank JS, Demer LL,
Edwards PA, Watson AD, Lusis AJ. Atherosclerosis: basic
mechanisms oxidation, inflammation, and genetics.
Circulation. 1995;91:24882496.
16. Navab M, Hough GP, Stevenson LW, Drinkwater DC, Laks H, Fogelman AM. Monocyte migration into the subendothelial space of a coculture of adult human aortic endothelial and smooth muscle cells. J Clin Invest. 1988;82:18531863.
17. Navab M, Imes SS, Hama SY, Hough GP, Ross LA, Bork RW, Valente AJ, Berliner JA, Drinkwater DC, Laks H, Fogelman AM. Monocyte transmigration induced by modification of low density lipoprotein in cocultures of human aortic wall cells is due to induction of monocyte chemotactic protein 1 synthesis and is abolished by high density lipoprotein. J Clin Invest. 1991;88:20392046.
18.
Navab M, Berliner JA, Watson AD, Hama S, Territo MC,
Lusis AJ, Shih DM, Van Lenten BJ, Frank JS, Demer LL, Edwards PA,
Fogelman AM. The Yin and Yang of oxidation in the development of the
fatty streak. Arterioscler Thromb Vasc Biol. 1996;16:831842.
19.
Parthasarathy S, Khoo JC, Miller E, Barnett J, Witztum
JL, Steinberg D. Low density lipoprotein rich in oleic acid is
protected against oxidative modification: implications for dietary
prevention of atherosclerosis. Proc Natl Acad Sci
U S A. 1990;87:38943898.
20.
Reaven PD, Parthasarathy S, Grasse BJ, Miller E,
Almazan F, Mattson FH, Khoo JC, Steinberg D, Witztum JL. Feasibility of
using an oleate-rich diet to reduce the susceptibility of low-density
lipoprotein to oxidative modification in humans. Am J Clin
Nutr. 1991;54:701706.
21. Reaven P, Parthasarathy S, Grasse BJ, Miller E, Steinberg D, Witztum JL. Effects of oleate-rich and linoleate-rich diets on the susceptibility of low density lipoprotein to oxidative modification in mildly hypercholesterolemic subjects. J Clin Invest. 1993;91:668676.
22.
Reaven PD, Grasse BJ, Tribble DL. Effects of
linoleate-enriched and oleate-enriched diets in combination with
-tocopherol on the susceptibility of LDL and LDL
subfractions to oxidative modification in humans. Arterioscler
Thromb. 1994;14:557566.
23. Gumbiner B, Low CC, Reaven PD. Effects of a monounsaturated fatty acid-enriched hypocaloric diet on cardiovascular risk factors in obese NIDDM patients. Diabetes Care. 1997;21:915.[Abstract]
24. Mattson FH, Grundy SM. Comparison of effects of dietary saturated, monounsaturated, and polyunsaturated fatty acids on plasma lipids and lipoproteins in man. J Lipid Res. 1985;26:194202.[Abstract]
25. Rumsey SC, Stucchi AF, Nicolosi RJ, Ramakrishnan R, Deckelbaum R. Human plasma LDL cryopreserved with sucrose maintains in vivo kinetics indistinguishable from freshly isolated human LDL in cynomolgus monkeys. J Lipid Res. 1994;35:15921598.[Abstract]
26. Lefevre G, Myers I, Peynet J, Couderc R. Effect of sucrose/-80°C storage of plasma on between-site values of low-density lipoprotein susceptibility to copper-induced oxidation. Clin Chim Acta. 1997;258:249255.[Medline] [Order article via Infotrieve]
27.
Folch J, Lees M, Sloane-Stanley GH. A simple method for
the isolation and purification of total lipides from animal tissues.
J Biol Chem. 1957;226:497509.
28. Esterbauer H, Striegl G, Puhl H, Rotheneder M. Continuous monitoring of in vitro oxidation of human low density lipoprotein. Free Radic Res Commun. 1989;6:6775.[Medline] [Order article via Infotrieve]
29. Yagi K. A simple fluorometric assay for lipoperoxides in blood plasma. Biochem Res. 1976;15:212216.
30.
Benz D, Mol M, Ezaki M, Mori-Ito N, Zelan, I,
Miyanohara A, Friedman T, Steinberg D, Witztum JL. Enhanced levels of
lipoperoxides in low density in lipoprotein incubated with murine
fibroblasts expressing high levels of human
15-lipoxygenase. J Biol Chem. 1995;270:51915197.
31.
Sigari F, Lee C, Horkko S, Reaven P. Fibroblasts that
overexpress 15-lipoxygenase generate bioactive and
minimally modified low density lipoprotein. Arterioscler Thromb
Vasc Biol. 1997;17:36393645.
32. Boyum A. Separation of leukocytes from blood and bone marrow. Scand J Clin Lab Invest. 1968;97:7.
33.
Berliner JA, Territo M, Almada L, Carter A, Shofonsky
E, Fogelman AM. Monocyte chemotactic factor produced by
endothelial cells. Arterioscler Thromb. 1986;6:254258.
34. Navab M, Ross LA, Hama S, Liao F, Hough GP, Drinkwater DC, Laks H, Fogelman AM. Interactions of human aortic wall cells in co-culture. Atherosclerosis. 1991;23:153160.
35. Gunstone FD, Herwood JL, Padley FB. The Lipid Handbook. London, UK: Chapman & Hall; 1994.
36. Visioli F, Galli C. Natural antioxidants and prevention of coronary heart disease: the potential role of olive oil and its minor constituents. Nutr Metab Cardiovasc Dis. 1995;5:306313.
37. Visioli F, Bellomo G, Montedoro G, Galli C. Low density lipoprotein oxidation is inhibited in vitro by olive oil constituents. Atherosclerosis. 1995;117:2532.[Medline] [Order article via Infotrieve]
38. Visioli F, Galli C. Oleuropein projects low density lipoprotein from oxidation. Life Sci. 1994;55:19651971.[Medline] [Order article via Infotrieve]
39.
Reaven PD, Grasse B, Barnett J. Effect of antioxidants
alone and in combination with monounsaturated fatty
acidenriched diets on lipoprotein oxidation. Arterioscler
Thromb Vasc Biol. 1996;16:14651472.
40.
Parfitt VJ, Rubba P, Bolton C, Marotta G, Hartog M,
Mancini M. A comparison of antioxidant status and free radical
peroxidation of plasma lipoproteins in healthy young persons from
Naples and Bristol. Eur Heart J. 1994;15:871876.
41.
Berry EM, Eisenberg D, Haratz D, Friedlander Y, Norman
Y, Kaufman NA, Stein Y. Effects of diets rich in
monounsaturated fatty acids on plasma lipoproteins:
the Jerusalem Nutrition Study: high MUFAs vs. high PUFAs. Am
J Clin Nutr. 1991;53:899907.
42. Liao F, Berliner JA, Mehrabian M, Navab M, Demer LL, Lusis AJ, Fogelman AM. Minimally modified low density lipoprotein is biologically active in vivo in mice. J Clin Invest. 1991;87:22532257.
43.
Watson AD, Leitinger N, Navab M, Faull KF, Horkko
S, Witztum JL, Palinski W, Schwenke D, Salomon R, Sha W, Subbanagounder
G, Fogelman AM, Berliner JA. Structural identification by mass
spectrometry of oxidized phospholipids in minimally oxidized low
density lipoprotein that induce monocyte/endothelial
interactions and evidence for their presence in vivo. J Biol
Chem. 1997;272:1359713607.
44.
Lee C, Barnett J, Reaven PD. Liposomes enriched in
oleic acid are less susceptible to oxidation and have less
proinflammatory activity when exposed to oxidizing conditions. J
Lipid Res. 1998;39:12391247.
45.
Scheidegger KJ, Butler S, Witztum JL.
Angiotensin II increases macrophage-mediated
modification of low density lipoprotein via a
lipoxygenase-dependent pathway. J Biol
Chem. 1997;272:2160921615.
46. Puhl H, Waeg G, Esterbauer H. Methods to determine oxidation of low-density lipoproteins. Methods Enzymol. 1997;233:425441.
47.
Trichopoulou A, Kouris-Blazos A, Wahlqvist ML,
Gnardellis C, Lagiou P, Polychronopoulous E, Vassilakou T, Lipworth L,
Trichopoulos D. Diet and overall survival in elderly people.
BMJ. 1995;311:14571460.
48. De Lorgeril M, Salen P, Martin JL, Mamelle N, Monjaud I, Touboul P, Delaye J. Effect of a Mediterranean type of diet on the rate of cardiovascular complications in patients with coronary artery disease: insights into the cardioprotective effect of certain nutriments. J Am Coll Cardiol. 1996;28:11031108.[Abstract]
49.
De Lorgeril M, Renaud S, Mamelle N, Salen P, Martin JL,
Monjaud I, Guidollet J, Touboul P, Delaye J. Mediterranean
-linolenic acid-rich diet in secondary prevention of
coronary heart disease. Lancet. 1994;343:14541459.[Medline]
[Order article via Infotrieve]
50. Singh RB, Rastogi SS, Verma R, Bolaki L, Singh R. An Indian experiment with nutritional modulation in acute myocardial infarction. Am J Cardiol. 1992;69:879885.[Medline] [Order article via Infotrieve]
51. Renaud S, De Lorgeril M, Delaye J, Guidollet J, Jacquard F, Mamelle N, Martin J, Monjaud I, Salen P, Toubol P. Cretan Mediterranean diet for prevention of coronary heart disease. Am J Clin Nutr. 1995;61:1360S1370S.[Abstract]
This article has been cited by other articles:
![]() |
L. Iuliano, R. Monticolo, G. Straface, S. Zullo, F. Galli, M. Boaz, and S. Quattrucci Association of cholesterol oxidation and abnormalities in fatty acid metabolism in cystic fibrosis Am. J. Clinical Nutrition, September 1, 2009; 90(3): 477 - 484. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. S. Harris, D. Mozaffarian, E. Rimm, P. Kris-Etherton, L. L. Rudel, L. J. Appel, M. M. Engler, M. B. Engler, and F. Sacks Omega-6 Fatty Acids and Risk for Cardiovascular Disease: A Science Advisory From the American Heart Association Nutrition Subcommittee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Cardiovascular Nursing; and Council on Epidemiology and Prevention Circulation, February 17, 2009; 119(6): 902 - 907. [Full Text] [PDF] |
||||
![]() |
A. F.G. Cicero, S. Nascetti, M. C. Lopez-Sabater, R. Elosua, J. T. Salonen, K. Nyyssonen, H. E. Poulsen, H.-J. F. Zunft, H. Kiesewetter, K. de la Torre, et al. Changes in LDL Fatty Acid Composition as a Response to Olive Oil Treatment Are Inversely Related to Lipid Oxidative Damage: The EUROLIVE Study J. Am. Coll. Nutr., April 1, 2008; 27(2): 314 - 320. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Wassom, V. Mikkelineni, M. O. Bohn, and T. R. Rocheford QTL for Fatty Acid Composition of Maize Kernel Oil in Illinois High Oil x B73 Backcross-Derived Lines Crop Sci., January 16, 2008; 48(1): 69 - 78. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fisher, K. Lees, and J. D. Spence Nutrition and Stroke Prevention Stroke, September 1, 2006; 37(9): 2430 - 2435. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ambring, M. Johansson, M. Axelsen, L. Gan, B. Strandvik, and P. Friberg Mediterranean-inspired diet lowers the ratio of serum phospholipid n-6 to n-3 fatty acids, the number of leukocytes and platelets, and vascular endothelial growth factor in healthy subjects Am. J. Clinical Nutrition, March 1, 2006; 83(3): 575 - 581. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Ros Dietary cis-monounsaturated fatty acids and metabolic control in type 2 diabetes Am. J. Clinical Nutrition, September 1, 2003; 78(3): 617S - 625. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Toborek, Y. W. Lee, R. Garrido, S. Kaiser, and B. Hennig Unsaturated fatty acids selectively induce an inflammatory environment in human endothelial cells Am. J. Clinical Nutrition, January 1, 2002; 75(1): 119 - 125. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
ATVB Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1999 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |